PDL BioPharma, Inc. (PDLI) Tops Q2 EPS by 8c
Tweet Send to a Friend
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q2 EPS of $0.62 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
